Similar articles

• Combined prime-boost immunization with systemic and mucosal pneumococcal vaccines based on Pneumococcal surface protein A to enhance protection against lethal pneumococcal infections.

  Zhang Y, Guo X, Guo M, Chen X, Li B, Yu J, Gu T, Kong W, Wu Y. Zhang Y, et al. Immunol Res. 2019 Oct;67(4-5):398-407. doi: 10.1007/s12026-019-09107-6. Immunol Res. 2019. PMID: 31773490
• Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.

  Liu H, Patil HP, de Vries-Idema J, Wilschut J, Huckriede A. Liu H, et al. PLoS One. 2013 Jul 31;8(7):e69649. doi: 10.1371/journal.pone.0069649. Print 2013. PLoS One. 2013. PMID: 23936066 Free PMC article.
• Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.

  Howe SE, Konjufca VH. Howe SE, et al. PLoS One. 2015 Feb 24;10(2):e0118067. doi: 10.1371/journal.pone.0118067. eCollection 2015. PLoS One. 2015. PMID: 25710518 Free PMC article.
• Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.

  Ranasinghe C, Ramshaw IA. Ranasinghe C, et al. Expert Rev Vaccines. 2009 Sep;8(9):1171-81. doi: 10.1586/erv.09.86. Expert Rev Vaccines. 2009. PMID: 19722891 Review.
• Immune response versus mucosal tolerance to mucosally administered antigens.

  Mestecky J, Moldoveanu Z, Elson CO. Mestecky J, et al. Vaccine. 2005 Mar 7;23(15):1800-3. doi: 10.1016/j.vaccine.2004.11.009. Vaccine. 2005. PMID: 15734045 Review.